Iantrek

Iantrek company information, Employees & Contact Information

Explore related pages

Related company profiles:

Bio-interventional surgery

Company Details

Employees
49
Founded
-
Address
151 E Post Rd,
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
White Plains, New York
Looking for a particular Iantrek employee's phone or email?

Iantrek Questions

News

Iantrek Hits 2,000 Procedures for New Bio-Interventional Technology - AlloFlo™ Uveo - GlobeNewswire

Iantrek Hits 2,000 Procedures for New Bio-Interventional Technology - AlloFlo™ Uveo GlobeNewswire

Iantrek Announces Peer-Reviewed Publication Highlighting 12-Month Safety and Effectiveness Results for its Bio-Interventional Uveoscleral Outflow Technology in Open-Angle Glaucoma Patients - Yahoo Finance

Iantrek Announces Peer-Reviewed Publication Highlighting 12-Month Safety and Effectiveness Results for its Bio-Interventional Uveoscleral Outflow Technology in Open-Angle Glaucoma Patients Yahoo Finance

Iantrek Appoints Adam Szaronos as Chief Executive Officer - GlobeNewswire

Iantrek Appoints Adam Szaronos as Chief Executive Officer GlobeNewswire

Iantrek Announces First Commercial Cases of its C.Rex Micro-Interventional System for Trabecular Outflow Enhancement - Yahoo Finance

Iantrek Announces First Commercial Cases of its C.Rex Micro-Interventional System for Trabecular Outflow Enhancement Yahoo Finance

AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases - GlobeNewswire

AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases GlobeNewswire

Iantrek Announces 1-Year Clinical Results of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients - Yahoo Finance

Iantrek Announces 1-Year Clinical Results of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients Yahoo Finance

Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies - GlobeNewswire

Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies GlobeNewswire

Top Iantrek Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant